Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05341622 · ClinicalTrials.gov registry record · NA
Mailed FIT Outreach 2022
A NA study of Colorectal Cancer and Colon Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 5,460
- Enrollment target
- 1
- Study location
NCT05341622 is a NA study of Colorectal Cancer and Colon Cancer that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 5,460 participants, above the 1,496-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (265% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05341622, a NA study of Colorectal Cancer and Colon Cancer, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,460 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to evaluate different approaches to increase colorectal cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase response rate to mailed fecal immunochemical test (FIT) kits among eligible patients, including differentiated packaging, sending text reminders, and personalized reminders.
Conditions Studied
Interventions
- BEHAVIORAL Text
- BEHAVIORAL Reminder
- BEHAVIORAL Differentiated Box
- BEHAVIORAL Standard Mail
- BEHAVIORAL No Text
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,460 participants |
| Start Date | 2022-05-27 |
| Est. Completion | 2022-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05341622
The ClinicalTrials.gov registry entry for NCT05341622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,460 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,496-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (265% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 5 interventions - of which Text is the first listed.
NCT05341622 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05341622 about?
NCT05341622 is a clinical study titled "Mailed FIT Outreach 2022". This project aims to evaluate different approaches to increase colorectal cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase response rate to mailed fecal immunochemic...
What is the current status of trial NCT05341622?
This trial is currently completed. It is a NA study. The enrollment target is 5,460 participants. The study started on 2022-05-27. Estimated completion is 2022-12-13.
What conditions does trial NCT05341622 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colon Cancer.
What interventions are being tested in trial NCT05341622?
The interventions under investigation include: Text (BEHAVIORAL), Reminder (BEHAVIORAL), Differentiated Box (BEHAVIORAL), Standard Mail (BEHAVIORAL), No Text (BEHAVIORAL).
Who is sponsoring clinical trial NCT05341622?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05341622 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.